Recommended Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Clinical and Molecular Hepatology | RNAi Combined with PEGIFNα Enhances Antiviral Immunity in Chronic Hepatitis B by Remodeling T/B Cell Interaction Networks
2026-11-15
【Frontier Express】Molecular Cancer | IGF2BP3 Promotes Esophageal Squamous Cell Carcinoma Progression and M2 Macrophage Polarization via USP36-Mediated β-Catenin Stabilization
2026-11-15
【Frontier Express】Cancer Cell | Antigen-Specific T-bet+ CD8+ T Cell Subsets Predict Pathologic Response to Neoadjuvant Immunotherapy in Melanoma
2026-11-14
【Frontier Express】Nature Communications | Neoadjuvant Pepinemab Combined with Immune Checkpoint Inhibitors Remodels the Tumor Microenvironment in Resectable Metastatic Melanoma
2026-11-13
【Frontier Express】Nature Communications | Differential Analysis of T Cell Correlates of COVID-19 Risk After a Second Booster
2026-11-13
【Frontier Express】Nature Communications | Phase II Study of FMT Combined with Atezolizumab-Bevacizumab for Immunotherapy-Refractory Hepatocellular Carcinoma
2026-11-12
【Frontier Express】Molecular Neurodegeneration | Phase 1 Clinical Trial Results of the Aβ Vaccine AV-1959R in Preclinical Alzheimer's Disease Populations
2026-11-12






